These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 19647176

  • 21. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
    Liepe K, Kotzerke J, Lambert B.
    J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
    [No Abstract] [Full Text] [Related]

  • 22. 188Re-labeled bisphosphonates as potential bifunctional agents for therapy in patients with bone metastases.
    El-Mabhouh A, Mercer JR.
    Appl Radiat Isot; 2005 Apr; 62(4):541-9. PubMed ID: 15701408
    [Abstract] [Full Text] [Related]

  • 23. A kit formulation for the preparation of 188Re-lipiodol: preclinical studies and preliminary therapeutic evaluation in patients with unresectable hepatocellular carcinoma.
    Boschi A, Uccelli L, Duatti A, Colamussi P, Cittanti C, Filice A, Rose AH, Martindale AA, Claringbold PG, Kearney D, Galeotti R, Turner JH, Giganti M.
    Nucl Med Commun; 2004 Jul; 25(7):691-9. PubMed ID: 15208496
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and application of 188Re-MN-16ET/Lipiodol in a hepatocellular carcinoma animal model.
    Tang IC, Luo TY, Liu SW, Chan SH, Kung HC, Peng CL, Lin WY, Chang Y, Lin WJ.
    Nucl Med Biol; 2011 Oct; 38(7):1043-52. PubMed ID: 21831647
    [Abstract] [Full Text] [Related]

  • 25. Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.
    Molina-Trinidad EM, de Murphy CA, Jung-Cook H, Stack EM, Pedraza-Lopez M, Morales-Marquez JL, Serrano GV.
    J Pharm Pharmacol; 2010 Apr; 62(4):456-61. PubMed ID: 20604834
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study.
    Bernal P, Raoul JL, Stare J, Sereegotov E, Sundram FX, Kumar A, Jeong JM, Pusuwan P, Divgi C, Zanzonico P, Vidmar G, Buscombe J, Chau TT, Saw MM, Chen S, Ogbac R, Dondi M, Padhy AK.
    Semin Nucl Med; 2008 Mar; 38(2):S40-5. PubMed ID: 18243842
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer.
    Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S.
    Nucl Med Commun; 2009 May; 30(5):362-7. PubMed ID: 19282794
    [Abstract] [Full Text] [Related]

  • 35. Radionuclide therapy for hepatocellular carcinoma: indication, cost and efficacy.
    Bal CS, Kumar A.
    Trop Gastroenterol; 2008 May; 29(2):62-70. PubMed ID: 18972764
    [Abstract] [Full Text] [Related]

  • 36. Treatment of hepatocellular carcinoma by radioembolization using 90Y microspheres.
    Sangro B, Bilbao JI, Iñarrairaegui M, Rodriguez M, Garrastachu P, Martinez-Cuesta A.
    Dig Dis; 2009 May; 27(2):164-9. PubMed ID: 19546555
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Assessment of 186Re chelate-conjugated bisphosphonate for the development of new radiopharmaceuticals for bones.
    Uehara T, Jin ZL, Ogawa K, Akizawa H, Hashimoto K, Nakayama M, Arano Y.
    Nucl Med Biol; 2007 Jan; 34(1):79-87. PubMed ID: 17210464
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.